
PetMed Express
(NASDAQ) PETS
PetMed Express Financials at a Glance
Market Cap
$42.32MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Revenue (TTM)
$179.02M
Net Income (TTM)
-$57.29M
EPS (TTM)
-$2.75
P/E Ratio
-0.72
Dividend
$0.00
Beta (Volatility)
0.92 (Low)
Dividend
$0.00
Beta (Volatility)
0.92 (Low)
Price
$1.95
Volume
216,479.578
Open
$1.94
Price
$1.95
Volume
216,479.578
Open
$1.94
Previous Close
$1.96
Daily Range
$1.90 - $1.99
52-Week Range
$1.57 - $4.10
Estimated Earnings Date
Aug 6, 2026
Dividend
$0.00
Beta (Volatility)
0.92 (Low)
Price
$1.95
Volume
216,479.578
Open
$1.94
Previous Close
$1.96
Daily Range
$1.90 - $1.99
52-Week Range
$1.57 - $4.10
Estimated Earnings Date
Aug 6, 2026
PETS News

Is PetMed's 4.3% Yield Safe?
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout PetMed Express
Industry
Specialty Retail
Sector
Consumer DiscretionaryEmployees
189
CEO
Leslie C. G. Campbell
Website
www.1800petmeds.comHeadquarters
Delray Beach, FL 33445, US
PETS Financials
Key Financial Metrics (TTM)
Gross Margin
22.81%
Operating Margin
-17.55%
Net Income Margin
-32.00%
Return on Equity
-146.59%
Return on Capital
-106.58%
Return on Assets
-70.56%
Earnings Yield
-1.39%
Dividend Yield
0.00%
Payout Ratio
-0.04%
Stock Overview
Market Cap
$42.32MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Shares Outstanding
21.37M
Volume
216.48K
Avg. Volume
653.82K
Financials (TTM)
Gross Profit
$40.83M
Operating Income
-$31.42M
EBITDA
-$48.90M
Operating Cash Flow
-$28.39M
Capital Expenditure
-$4.62M
Free Cash Flow
-$33.01M
Cash & ST Invst.
$21.41M
Total Debt
$535.00K
PetMed Express Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$42.82M
-7.9%
Gross Profit
$6.84M
-63.9%
Gross Margin
15.97%
N/A
Market Cap
$42.32MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
N/A
Market Cap/Employee
$147.44K
N/A
Employees
287
N/A
Net Income
-$4.06M
+65.1%
EBITDA
-$3.27M
-18.9%
Quarterly Fundamentals
Total Cash
$21.41M
-60.9%
Total Debt
$535.00K
-46.3%
Accounts Receivable
$1.91M
-17.7%
Inventory
$13.61M
-16.0%
Long Term Debt
$42.00K
-92.1%
Short Term Debt
$493.00K
+6.9%
Return on Assets
-70.56%
N/A
Return on Invested Capital
-1.08%
N/A
Free Cash Flow
-$5.46M
-218.2%
Operating Cash Flow
-$4.74M
-167.7%






